Abnormal response to inotropic stimulation in young asymptomatic type I diabetic patients demonstrated by serial gated myocardial perfusion SPECT imaging

• Published in: European journal of nuclear medicine and molecular imaging Vol. 32; no. 11; pp. 1317 - 1323
• Main Authors: Weytjens, C., Cosyns, B., Van Camp, G., Daniels, C., Spincemaille, K., Dupont, A., Franken, P. R.
• Format: Journal Article
• Language: English
• Published: Germany Springer Nature B.V 01.11.2005
• Subjects: Adult; Cardiotonic Agents - administration & dosage; Diabetes Mellitus, Type 1 - complications; Diabetes Mellitus, Type 1 - diagnostic imaging; Diabetes Mellitus, Type 1 - drug therapy; Dobutamine - administration & dosage; Dose-Response Relationship, Drug; Gated Blood-Pool Imaging - methods; Humans; Male; Stroke Volume - drug effects; Tomography, Emission-Computed, Single-Photon - methods; Treatment Outcome; Ventricular Dysfunction, Left - diagnostic imaging; Ventricular Dysfunction, Left - drug therapy; Ventricular Dysfunction, Left - etiology
• ISSN: 1619-7070; 1619-7089
• DOI: 10.1007/s00259-005-1847-3

In subjects without underlying cardiac disease dobutamine is known to enhance systolic LV function and LV relaxation. As end-systolic (ES) and end-diastolic (ED) volumes (V) can be derived from gated SPECT we intent to study these volumes and their response to dobutamine in order to have a better understanding of the mechanism by which stroke volume (SV) increases during dobutamine infusion. We intent to do this in normal controls and in young diabetic subjects. After injection of sestamibi, serial gated SPECT were obtained at baseline, and during low doses of dobutamine infusion in 12 asymptomatic type I diabetic patients, and in 12 age matched controls. LV EDV, ESV, SV and EF were calculated with the QGS program. Gated SPECT showed comparable LV EF and SV in both groups at rest. There was a significant increase in LVEF and SV during dobutamine infusion but in the diabetic patients the increase in SV was due to a decrease in ESV from 25+/-5 to 20+/-6 ml/m2 (p=0.002) and no change in EDV. In normal controls, the increase in EF was due to an increase in EDV from 69+/-10 to 73+/-12 ml/m2 (p=0.002) with no significant change in ESV. These data confirm the presence of subclinical abnormalities of diastolic function in asymptomatic type I diabetic patients and show differences in adaptation to inotropic stimulation in order to preserve the increase in stroke volume and LV ejection fraction.